Education
About Us
Working with TipRanks
Follow Us
Organogenesis Holdings Inc (ORGO)
NASDAQ:ORGO
RESEARCH TOOLSreports
ORGO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.17 - $6.71
Previous CloseN/A
Volume97.61K
Average Volume (3M)2.62M
Market Cap
$639.21M
Enterprise Value$394.49M
Total Cash (Recent Filing)$21.29M
Total Debt (Recent Filing)$59.26M
Price to Earnings (P/E)900.0
Beta1.55
Next Earnings
May 07, 2025EPS Estimate
-0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding126,828,094
10 Day Avg. Volume7,010,730
30 Day Avg. Volume2,616,452
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.42
Price to Cash Flow (P/CF)15.70
P/FCF Ratio21.10
Enterprise Value/Market Cap0.62
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.08
Enterprise Value/Ebitda64.06
Forecast
1Y Price Target
$6.00Price Target Upside19.05% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
---
Organogenesis Holdings News
PremiumCompany Announcements
Organogenesis Holdings Reports Strong Q4 Earnings Amid Challenges
PremiumCompany Announcements
Organogenesis Holdings Reports Strong Q4 2024 Results
---
Bulls Say, Bears Say
Bulls Say
Debt ManagementThe recent debt reduction by Organogenesis Holdings has contributed to a higher price target, reflecting improved financial stability.
Revenue PerformanceRevenue in the fourth quarter exceeded expectations with a strong sales performance, indicating robust demand for Organogenesis's products.
Bears Say
Guidance OutlookThe guidance for the first quarter is below consensus due to expected impacts from LCDs, suggesting potential short-term challenges.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ORGO FAQ
What was Organogenesis Holdings Inc’s price range in the past 12 months?
Organogenesis Holdings Inc lowest stock price was $2.17 and its highest was $6.71 in the past 12 months.
What is Organogenesis Holdings Inc’s market cap?
Organogenesis Holdings Inc’s market cap is $639.21M.
When is Organogenesis Holdings Inc’s upcoming earnings report date?
Organogenesis Holdings Inc’s upcoming earnings report date is May 07, 2025 which is in 62 days.
How were Organogenesis Holdings Inc’s earnings last quarter?
Organogenesis Holdings Inc released its earnings results on Feb 27, 2025. The company reported $0.04 earnings per share for the quarter, beating the consensus estimate of -$0.011 by $0.051.
Is Organogenesis Holdings Inc overvalued?
According to Wall Street analysts Organogenesis Holdings Inc’s price is currently Undervalued.
Does Organogenesis Holdings Inc pay dividends?
Organogenesis Holdings Inc does not currently pay dividends.
What is Organogenesis Holdings Inc’s EPS estimate?
Organogenesis Holdings Inc’s EPS estimate is -0.06.
How many shares outstanding does Organogenesis Holdings Inc have?
Organogenesis Holdings Inc has 126,828,094 shares outstanding.
What happened to Organogenesis Holdings Inc’s price movement after its last earnings report?
Organogenesis Holdings Inc reported an EPS of $0.04 in its last earnings report, beating expectations of -$0.011. Following the earnings report the stock price went up 102.28%.
Which hedge fund is a major shareholder of Organogenesis Holdings Inc?
Currently, no hedge funds are holding shares in ORGO
---
Organogenesis Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.00 (19.05% Upside)
$6.00 (19.05% Upside)
Blogger Sentiment
Bullish
ORGO Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 31.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▲ 1.9%
Last 30 Days ▼ 3.1%
Last 30 Days ▼ 3.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
75.00%
12-Months-Change
Fundamentals
Return on Equity
0.33%
Trailing 12-Months
Asset Growth
8.23%
Trailing 12-Months
Company Description
Organogenesis Holdings Inc
Organogenesis Holdings, Inc. is a regenerative medical company. It focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.
---
ORGO Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlights strong financial performance with significant revenue growth, successful debt reduction, and progress in clinical programs. However, challenges remain with market uncertainty due to delayed LCD implementation and competitive pressures. Despite these challenges, the company's strategic initiatives and financial health position it well for future opportunities.Read More>---
ORGO Stock 12 Month Forecast
Average Price Target
$6.00
▲(19.05% Upside)
Technical Analysis
Best Analysts Covering ORGO
1 Year
1 Year Success Rate
8/27 ratings generated profit
1 Year Average Return
-13.10%
reiterated a buy rating 2 days ago
Copying Ryan Zimmerman's trades and holding each position for 1 Year would result in 29.63% of your transactions generating a profit, with an average return of -13.10% per trade.
---